139 related articles for article (PubMed ID: 1678420)
21. Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease.
Ikeda T; Furukawa Y; Mashimoto S; Takahashi K; Yamada M
Acta Psychiatr Scand; 1990 Oct; 82(4):327-9. PubMed ID: 2260490
[TBL] [Abstract][Full Text] [Related]
22. Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multi-infarct dementia.
Degrell I; Hellsing K; Nagy E; Niklasson F
Arch Gerontol Geriatr; 1989; 9(2):123-35. PubMed ID: 2686573
[TBL] [Abstract][Full Text] [Related]
23. Tau protein is a potential biological marker for normal pressure hydrocephalus.
Kudo T; Mima T; Hashimoto R; Nakao K; Morihara T; Tanimukai H; Tsujio I; Koike Y; Tagami S; Mori H; Nakamura Y; Tanaka T; Mori K; Takeda M
Psychiatry Clin Neurosci; 2000 Apr; 54(2):199-202. PubMed ID: 10803815
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine.
Alhainen K; Sirviö J; Helkala EL; Reinikainen K; Riekkinen P
Neurosci Lett; 1991 Sep; 130(1):46-8. PubMed ID: 1684233
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders.
Cacabelos R; Barquero M; García P; Alvarez XA; Varela de Seijas E
Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):455-8. PubMed ID: 1784142
[TBL] [Abstract][Full Text] [Related]
26. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.
Tato RE; Frank A; Hernanz A
J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):280-3. PubMed ID: 7545739
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA
Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746
[TBL] [Abstract][Full Text] [Related]
28. Increased CSF levels of somatostatin in patients with brain tumours and intracranial hypertension.
Stepień H; Stawowy A; Cieślak D; Brzeziński J; Pawlikowski M
Horm Metab Res; 1986 Aug; 18(8):555-7. PubMed ID: 2875924
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
30. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.
Poca MA; Mataró M; Sahuquillo J; Catalán R; Ibañez J; Galard R
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):298-304. PubMed ID: 11181849
[TBL] [Abstract][Full Text] [Related]
31. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
[TBL] [Abstract][Full Text] [Related]
32. [A preliminary study of cerebrospinal fluid cytology in aged patients with dementia].
Hou Y
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Jun; 25(3):154-6, 191. PubMed ID: 1395943
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.
Raskind MA; Peskind ER; Lampe TH; Risse SC; Taborsky GJ; Dorsa D
Arch Gen Psychiatry; 1986 Apr; 43(4):382-8. PubMed ID: 2869744
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
Santangelo R; Cecchetti G; Bernasconi MP; Cardamone R; Barbieri A; Pinto P; Passerini G; Scomazzoni F; Comi G; Magnani G
J Alzheimers Dis; 2017; 60(1):183-200. PubMed ID: 28826180
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
[TBL] [Abstract][Full Text] [Related]
36. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D
J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients.
Francis PT; Bowen DM; Neary D; Palo J; Wikstrom J; Olney J
Neurobiol Aging; 1984; 5(3):183-6. PubMed ID: 6151122
[TBL] [Abstract][Full Text] [Related]
38. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
Sunderland T; Rubinow DR; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
Am J Psychiatry; 1987 Oct; 144(10):1313-6. PubMed ID: 2889377
[TBL] [Abstract][Full Text] [Related]
39. Calcium and phosphorus levels in serum and CSF in dementia.
Subhash MN; Padmashree TS; Srinivas KN; Subbakrishna DK; Shankar SK
Neurobiol Aging; 1991; 12(4):267-9. PubMed ID: 1961355
[TBL] [Abstract][Full Text] [Related]
40. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.
Green AJ; Harvey RJ; Thompson EJ; Rossor MN
Neurosci Lett; 1999 Jan; 259(2):133-5. PubMed ID: 10025576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
